Update on bradykinin-mediated angioedema in 2020

Therapies - Tập 75 - Trang 195-205 - 2020
Marion Lepelley1, Claire Bernardeau1, Federica Defendi2, Julia Crochet3, Michel Mallaret1, Laurence Bouillet4
1Centre régional de pharmacovigilance, centre hospitalier universitaire Grenoble-Alpes, 38000 Grenoble, France
2Laboratoire d’immunologie, centre hospitalier universitaire Grenoble-Alpes, 38000 Grenoble, France
3Service de dermatologie et allergologie, centre hospitalier Métropole Savoie, 73000 Chambéry, France
4Centre de référence national des angioedèmes (CREAK), centre hospitalier universitaire Grenoble-Alpes, 38000 Grenoble, France

Tài liệu tham khảo

Stone, 2017, Angiotensin-converting enzyme inhibitor and other drug-associated angioedema, Immunol Allergy Clin North Am, 37, 483, 10.1016/j.iac.2017.04.006 Bisha, 2018, The role of bradykinin receptor type 2 in spontaneous extravasation in mice skin: implications for non-allergic angio-oedema, Br J Pharmacol, 175, 1607, 10.1111/bph.14166 Obtułowicz, 2016, Bradykinin-mediated angioedema, Pol Arch Med Wewn, 126, 76 Campos, 2000, Neurokinin mediation of edema and inflammation, Neuropeptides, 34, 314, 10.1054/npep.2000.0823 Sulpizio, 2004, The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat, J Pharmacol Exp Ther, 309, 1141, 10.1124/jpet.103.064105 Moreau, 2005, The kallikrein-kinin system: current and future pharmacological targets, J Pharmacol Sci, 99, 6, 10.1254/jphs.SRJ05001X Russell, 1996, Substance P and neurokinin A metabolism by cultured human skeletal muscle myocytes and fibroblasts, Peptides, 17, 1397, 10.1016/S0196-9781(96)00201-X Hahn, 2018, Unnecessary abdominal interventions in patients with hereditary angioedema, J Dtsch Dermatol Ges, 16, 1443 Bork, 2000, Asphyxiation by laryngeal edema in patients with hereditary angioedema, Mayo Clin Proc, 75, 349, 10.4065/75.4.349 Bork, 2001, Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema, Arch Intern Med, 161, 714, 10.1001/archinte.161.5.714 Bork, 2012, Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency, J Allergy Clin Immunol, 130, 692, 10.1016/j.jaci.2012.05.055 Xu, 2014, Upper airway edema in 43 patients with hereditary angioedema, Ann Allergy Asthma Immunol, 112, 10.1016/j.anai.2014.03.003 Moldovan, 2018, Consequences of misdiagnosed and mismanaged hereditary angioedema laryngeal attacks: an overview of cases from the Romanian registry, Case Rep Emerg Med, 2018, 6363787 Crochet, 2019, Bradykinin mechanism is the main responsible for death by isolated asphyxiating angioedema in France, Clin Exp Allergy, 49, 252, 10.1111/cea.13297 Bernstein, 2013, HAE update: epidemiology and burden of disease, Allergy Asthma Proc, 34, 3, 10.2500/aap.2013.34.3623 Kaplan, 2010, The plasma bradykinin-forming pathways and its interrelationships with complement, Mol Immunol, 47, 2161, 10.1016/j.molimm.2010.05.010 Kaplan, 2011, Bradykinin and the pathogenesis of hereditary angioedema, World Allergy Organ J, 4, 73, 10.1097/WOX.0b013e318216b7b2 Caccia, 2014, Pathophysiology of hereditary angioedema, Pediatr Allergy Immunol Pulmonol, 27, 159, 10.1089/ped.2014.0425 Kramer, 1991, Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema, J Clin Invest, 87, 1614, 10.1172/JCI115175 Roche, 2005, Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohort, Hum Mutat, 26, 135, 10.1002/humu.20197 Zingale, 2006, Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management, Immunol Allergy Clin North Am, 26, 669, 10.1016/j.iac.2006.08.002 Mandle, 1994, Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor, J Immunol, 152, 4680, 10.4049/jimmunol.152.9.4680 Cacoub, 2001, A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus, Arthritis Rheum, 44, 1836, 10.1002/1529-0131(200108)44:8<1836::AID-ART321>3.0.CO;2-Y Bork, 2018, Hereditary angioedema with a mutation in the plasminogen gene, Allergy, 73, 442, 10.1111/all.13270 Bouillet, 2008, Disease expression in women with hereditary angioedema, Am J Obstet Gynecol, 199, 484.e1, 10.1016/j.ajog.2008.04.034 Bouillet, 2017, Hereditary angioedema with normal C1 inhibitor in a French cohort: clinical characteristics and response to treatment with icatibant, Immun Inflamm Dis, 5, 29, 10.1002/iid3.137 Belbézier, 2018, Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: three additional French families, Allergy, 73, 2237, 10.1111/all.13543 Karadža-Lapić, 2018, The incidence and frequency of various causes of angioedema in emergency medicine, Acta Medica Acad, 47, 11, 10.5644/ama2006-124.210 Sachs, 2018, Drug-induced angioedema: focus on bradykinin, Hautarzt Z Dermatol Venerol Verwandte Ge, 69, 298, 10.1007/s00105-017-4119-9 Nussberger, 2002, Bradykinin-mediated angioedema, N Engl J Med, 347, 621, 10.1056/NEJM200208223470820 Fryer, 2008, Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema, Br J Pharmacol, 153, 947, 10.1038/sj.bjp.0707641 Miller, 2008, Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors, Hypertension, 51, 1624, 10.1161/HYPERTENSIONAHA.108.110270 Banerji, 2017, Epidemiology of ACE inhibitor angioedema utilizing a large electronic health record, J Allergy Clin Immunol Pract, 5, 744, 10.1016/j.jaip.2017.02.018 Morimoto, 2004, An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors, J Eval Clin Pract, 10, 499, 10.1111/j.1365-2753.2003.00484.x Hoover, 2010, Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors, Clin Exp Allergy J, 40, 50 Slater, 1988, Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition, JAMA, 260, 967, 10.1001/jama.1988.03410070095035 Hedner, 1992, Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors, BMJ, 304, 941, 10.1136/bmj.304.6832.941 Orr, 2004, Intermittent visceral edema induced by long-term enalapril administration, Ann Pharmacother, 38, 825, 10.1345/aph.1D458 Beltrami, 2011, Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema, J Hypertens, 29, 2273, 10.1097/HJH.0b013e32834b4b9b Scott, 2018, Dipeptidyl peptidase-4 inhibitor induced angioedema — an overlooked and potentially lethal adverse drug reaction?, Curr Diabetes Rev, 14, 327, 10.2174/1573399813666170214113856 Lefebvre, 2002, Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema, Hypertension, 39, 460, 10.1161/hy0202.103054 Brown, 2009, Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema, Hypertension, 54, 516, 10.1161/HYPERTENSIONAHA.109.134197 Kostis, 2004, Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial, Am J Hypertens, 17, 103, 10.1016/j.amjhyper.2003.09.014 Myslimi, 2016, Orolingual angioedema during or after thrombolysis for cerebral ischemia, Stroke, 47, 1825, 10.1161/STROKEAHA.116.013334 Gauberti, 2018, Impact of bradykinin generation during thrombolysis in ischemic stroke, Front Med, 5, 195, 10.3389/fmed.2018.00195 Grandeau, 2014, Bradykinin mediated angioedema with ACE inhibitor in combination with immunosupressive agents, Therapie, 69, 189, 10.2515/therapie/2013071 Duerr, 2010, Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients, Clin J Am Soc Nephrol, 5, 703, 10.2215/CJN.07371009 Nedelea, 2019, Isolated angioedema: an overview of clinical features and etiology, Exp Ther Med, 17, 1068 Bork, 2006, Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency, Am J Gastroenterol, 101, 619, 10.1111/j.1572-0241.2006.00492.x Courtier, 2009, Case 151: hereditary angioedema in the duodenum, Radiology, 253, 564, 10.1148/radiol.2532080598 Jalaj, 2013, Gastrointestinal manifestations, diagnosis, and management of hereditary angioedema, J Clin Gastroenterol, 47, 817, 10.1097/MCG.0b013e31829e7edf Patel, 2015, Hereditary angioedema and gastrointestinal complications: an extensive review of the literature, Case Rep Immunol, 2015, 925861 Floccard, 2015, Emergency management of bradykinin-mediated angioedema, Presse Med, 44, 70, 10.1016/j.lpm.2014.09.012 Bork, 2003, Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency, Arch Intern Med, 163, 1229, 10.1001/archinte.163.10.1229 Sanuki, 2014, Perioperative management of tooth extractions for a patient with hereditary angioedema, J Oral Maxillofac, 72, 2421.e1, 10.1016/j.joms.2014.08.026 Martinez-Saguer, 2016, Erythema marginatum as an early symptom of hereditary angioedema: case report of 2 newborns, Pediatrics, 137, e20152411, 10.1542/peds.2015-2411 Aabom, 2017, Complement factor C4 activation in patients with hereditary angioedema, Clin Biochem, 50, 816, 10.1016/j.clinbiochem.2017.04.007 Gompels, 2002, A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency, J Clin Pathol, 55, 145, 10.1136/jcp.55.2.145 Zanichelli, 2017, Diagnosis, course, and management of angioedema in patients with acquired c1-inhibitor deficiency, J Allergy Clin Immunol Pract, 5, 1307, 10.1016/j.jaip.2016.12.032 Gobert, 2016, A nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment responses in 92 patients, Medicine (Baltimore), 95, e4363, 10.1097/MD.0000000000004363 Maurer, 2018, The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update, Allergy, 73, 1575, 10.1111/all.13384 Farkas, 2019, Hereditary angioedema: examining the landscape of therapies and preclinical therapeutic targets, Expert Opin Ther Targets, 23, 457, 10.1080/14728222.2019.1608949 Maurer, 2013, Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment, PloS One, 8, e53773, 10.1371/journal.pone.0053773 Craig, 2013, Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks, Ann Allergy Asthma Immunol, 111, 211, 10.1016/j.anai.2013.06.021 Riedl, 2016, Safety and usage of C1-inhibitor in hereditary angioedema: berinert registry data, J Allergy Clin Immunol Pract, 4, 963, 10.1016/j.jaip.2016.04.018 Cicardi, 2010, Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema, N Engl J Med, 363, 532, 10.1056/NEJMoa0906393 Makani, 2012, Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors, Am J Cardiol, 110, 383, 10.1016/j.amjcard.2012.03.034 Caldeira, 2012, Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis, Am J Cardiovasc Drugs, 12, 263, 10.1007/BF03261835 Riha, 2017, Novel Therapies for angiotensin-converting enzyme inhibitor-induced angioedema: a systematic review of current evidence, J Emerg Med, 53, 662, 10.1016/j.jemermed.2017.05.037 Lawlor, 2018, Pharmacotherapy for angiotensin-converting enzyme inhibitor-induced angioedema: a systematic review, Otolaryngol Head Neck Surg, 158, 232, 10.1177/0194599817737974 Nosbaum, 2013, Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema, Rev Med Interne, 34, 209, 10.1016/j.revmed.2012.12.017 Javaud, 2018, Specialist advice support for management of severe hereditary angioedema attacks: a multicenter cluster-randomized controlled trial, Ann Emerg Med, 72, 10.1016/j.annemergmed.2018.01.053 Binkley, 2010, Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions, Allergy Asthma Clin Immunol, 6, 16, 10.1186/1710-1492-6-16 Aygören-Pürsün, 2018, Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema, N Engl J Med, 379, 352, 10.1056/NEJMoa1716995 Ferrone, 2019, IONIS-PKKRx a novel antisense inhibitor of prekallikrein and bradykinin production, Nucleic Acid Ther, 29, 82, 10.1089/nat.2018.0754 Cao, 2018, Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation, J Allergy Clin Immunol, 142, 1355, 10.1016/j.jaci.2018.06.014 Qiu, 2019, Gene therapy for C1 esterase inhibitor deficiency in a murine model of hereditary angioedema, Allergy, 74, 1081, 10.1111/all.13582